(Q44845267)

6 December 2017

Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade (English)

1 reference

6 December 2017

endocannabinoid system

0 references

4

Hiroyuki Tanaka

1 reference

6 December 2017

Kusnandar Anggadiredja

1

1 reference

6 December 2017

Masanori Nakamichi

2

1 reference

6 December 2017

Takato Hiranita

3

1 reference

6 December 2017

Yukihiro Shoyama

5

1 reference

6 December 2017

Shigenori Watanabe

6

1 reference

6 December 2017

Tsuneyuki Yamamoto

7

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

6 December 2017

Neuropsychopharmacology

1 reference

6 December 2017

29

1 reference

6 December 2017

1470-1478

1 reference

6 December 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300454

6 December 2017

0 references

cites work

Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Prostaglandin E2 attenuates SR141716A-precipitated withdrawal in tetrahydrocannabinol-dependent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Ice: a new dosage form of an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

EEG and behavioral effects of delta9-tetrahydrocannabinol in combination with stimulant drugs in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Precipitated and spontaneous withdrawal in rats tolerant to anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

A cannabinoid mechanism in relapse to cocaine seeking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Addictive potential of cannabinoids: the underlying neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Effect of peripheral 2-DG on opioid and neuropeptide Y gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Abstinence symptoms following oral THC administration to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Abstinence symptoms following smoked marijuana in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Methamphetamine self-administration by humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Effects of cannabinoids on the activities of mouse brain lipases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Methamphetamine-induced striatal dopamine neurotoxicity and cyclooxygenase-2 protein expression in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Neuroscience of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Antagonism of marihuana effects by indomethacin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Evidence for the involvement of cyclooxygenase activity in the development of cocaine sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Modulation of transmitter release via presynaptic cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Simultaneous monitoring of conditioned place preference and locomotor sensitization following repeated administration of cocaine and methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

A community survey of adverse effects of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Behavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Role of cannabinoid receptor in the brain as it relates to drug reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

Stimulant actions of delta9-tetrahydrocannabinol in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

Clinical relevance of cannabis tolerance and dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

Immunohistochemical localization of prostaglandin EP3 receptor in the rat nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

Activation of brain prostanoid EP3 receptors via arachidonic acid cascade during behavioral suppression induced by Delta8-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300454

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300454

1 reference

6 December 2017

1 reference